Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 10, 2001, Pages 1623-1629

  Zhao, Xue Qiao ^a   Yuan, Chun ^a   Hatsukami, Thomas S ^a   Frechette, Ellen Huss ^a   Kang, Xiao Jian ^a   Maravilla, Kenneth R ^a   Brown, B Greg ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerotic plaque; Lipid lowering therapy; MRI

Indexed keywords

ANTILIPEMIC AGENT; COLESTIPOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID COMPOSITION; LIPID STORAGE; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035723951     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1001.098463     Document Type: Article

References (46)

1. The pathogenesis of coronary artery disease and the acute coronary syndromes
2. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
3. Coronary plaque disruption
4. Stability and instability: Two faces of coronary atherosclerosis: The Paul Dudley White Lecture 1995
5. Lipid-lowering therapy
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: The Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Group
7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
8. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
9. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
10. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo
11. Phased-array magnetic resonance imaging of the carotid artery bifurcation: Preliminary results in healthy volunteers and a patient with atherosclerotic disease
12. Characterization of atherosclerosis with a 1.5-T imaging system
13. High resolution MR imaging of human arteries
14. MRI studies of atherosclerotic vascular disease: Structural evaluation and physiological measurements
15. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging
16. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, treatment of high blood cholesterol in adults (Adult Treatment Panel III)
17. Very intensive lipid therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction: A 10-year Familial Atherosclerosis Treatment Study (FATS) follow-up
18. Surface coil phased arrays for high resolution imaging of the carotid arteries
19. Characterization of atherosclerotic plaques at the carotid bifurcation: Correlation of high-resolution MR imaging with histologic analysis: Preliminary study
20. In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids
21. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization
22. High resolution MR imaging of atherosclerotic human coronary arteries ex vivo: Evaluation of plaque tissue contrast
23. Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets
24. Arterial fibrous protein in cynomolgus monkeys after atherogenic and regression diets
25. A study of atherosclerosis regression in Macaca mulatta, IV: Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl
26. Physiochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis
27. Can atherosclerotic plaques regress?: Anatomic and biochemical evidence from nonhuman animal models
28. Plaque hemorrhages, their genesis and their role in supra-plaque thrombosis and atherogenesis
29. Characteristics of the plaque under a coronary thrombus
30. Atherosclerotic plaque caps are locally weakened when macrophage density is increased
31. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
32. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophages, and smooth muscle cell content
33. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques
34. Human monocyte-derived macrophages express collagenase and induce collagen breakdown in atherosclerotic fibrous caps: Implication for plaque rupture
35. Location of stromelysin gene in atherosclerotic plaques using in-site hybridization
36. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death
37. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest
38. Composition of atherosclerotic plaques in coronary arteries in women less than 40 years of age with fatal coronary artery disease and implications for plaque reversibility
39. Composition of atherosclerotic plaques in the four major epicardial coronary arteries in patients greater than or equal to 90 years of age
40. Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia
41. Histologic characteristics of carotid artery plaque
42. Carotid plaque morphology and clinical events
43. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization
44. Noninvasive quantitative evaluation of atherosclerosis using MRI and image analysis
45. High-resolution 1H NMR spectral signature from human atheroma
46. Nuclear magnetic resonance microscopy of atheroma in human coronary arteries